{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:06Z","timestamp":1786649286169,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>To report outcomes in patients treated with low-dose lens-sparing intensity-modulated radiation therapy (IMRT) for diffuse choroidal hemangioma (DCH) associated subretinal (subfoveal) fluid (SRF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIAL AND METHODS:<\/jats:title>\n                    <jats:p>Retrospective interventional case series. 10 patients (11 eyes) treated with IMRT for diffuse choroidal hemangioma-associated SRF. Resolution of subretinal fluid, tumor regression, and best-corrected visual acuity (BCVA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The mean age was 9.9 years (range, 0.3\u201332), with 8 (73%) having exudative retinal detachment in the right eye. The rationale for treatment was the presence of SRF (11 eyes, 100%). At baseline, the maximal height of the tumor was 3.4 mm (range, 1.7\u20135.3). The mean BCVA in the affected eye was 40 ETDRS letters (range, 5\u201375). All eyes were treated with IMRT (lens-sparing) at a dose of 20 Gy in 10 fractions. Patients were followed up for an average duration of 7 years (range 6\u2013120 months), with 9 (82%) followed up for more than 2 years. Resolution of SRF was noted in all 11 (100%) eyes, with 6 (55%) eyes showing resolution within 3 months. Tumor response was observed in all eyes 11 (100%) (reduction or stabilization of tumor height), with the mean posttreatment height of 2.0 mm. BCVA improved or remained stable in 10 (91%). Radiation-related complications (cataracts, radiation retinopathy, radiation optic neuropathy) were not observed in any of the treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Low-dose lens-sparing IMRT is a highly effective treatment for diffuse choroidal hemangioma. IMRT resolves subretinal fluid, induces tumor regression, and preserves visual acuity in vast majority of cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tjo.tjo-d-24-00139","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T10:02:05Z","timestamp":1741600925000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Diffuse choroidal hemangioma: Ophthalmic outcomes following intensity-modulated radiation therapy"],"prefix":"10.4103","volume":"15","author":[{"given":"Jose Cijin","family":"Puthussery","sequence":"first","affiliation":[{"name":"Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adannia","family":"Ufondu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheen","family":"Cherian","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[{"name":"Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"R1-20250320","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2147\/OPTH.S35471","article-title":"Multifocal photodynamic therapy for diffuse choroidal hemangioma","volume":"6","author":"Ang","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"R2-20250320","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.ophtha.2013.07.058","article-title":"Diffuse Choroidal Hemangioma Management with Plaque Radiotherapy in 5 Cases","volume":"120","author":"Arepalli","year":"2013","journal-title":"Ophthalmol"},{"key":"R3-20250320","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000260226","article-title":"Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas","volume":"224","author":"Chan","year":"2010","journal-title":"Ophthalmologica"},{"key":"R4-20250320","doi-asserted-by":"crossref","first-page":"e29925","DOI":"10.1002\/pbc.29925","article-title":"Low-dose proton radiotherapy for pediatric choroidal hemangioma:A case series","volume":"69","author":"Franco","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20250320","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00417-015-3061-8","article-title":"Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with ruthenium-106 plaque radiotherapy","volume":"253","author":"Kubicka-Trz\u0105ska","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20250320","doi-asserted-by":"crossref","first-page":"452372","DOI":"10.1155\/2014\/452372","article-title":"Photodynamic therapy for diffuse choroidal hemangioma in Sturge-Weber syndrome","volume":"2014","author":"Monteiro","year":"2014","journal-title":"Case Rep Med"},{"key":"R7-20250320","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41433-018-0024-4","article-title":"Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome","volume":"32","author":"Randon","year":"2018","journal-title":"Eye (Lond)"},{"key":"R8-20250320","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bjo.81.4.267","article-title":"Long-term results after low dose ocular irradiation for choroidal haemangiomas","volume":"81","author":"Schilling","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R9-20250320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.survophthal.2010.08.002","article-title":"Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas","volume":"56","author":"Tsipursky","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"R10-20250320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.18240\/ijo.2020.03.22","article-title":"Ruthenium-106 plaque brachytherapy for the treatment of diffuse choroidal hemangioma in Sturge-Weber syndrome","volume":"13","author":"Yu","year":"2020","journal-title":"Int J Ophthalmol"},{"key":"R11-20250320","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.eye.6701474","article-title":"Photodynamic therapy of choroidal haemangioma associated with Sturge-Weber syndrome","volume":"19","author":"Singh","year":"2005","journal-title":"Eye (Lond)"},{"key":"R12-20250320","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00006982-199111040-00004","article-title":"Low dose ocular irradiation for diffuse choroidal hemangiomas associated with bullous nonrhegmatogenous retinal detachment","volume":"11","author":"Scott","year":"1991","journal-title":"Retina"},{"key":"R13-20250320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9394(98)00150-0","article-title":"Proton beam irradiation of choroidal hemangiomas","volume":"126","author":"Zografos","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R14-20250320","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.wneu.2019.08.138","article-title":"Gamma knife radiosurgery for choroidal hemangioma:A single-institute series","volume":"133","author":"Chung","year":"2020","journal-title":"World Neurosurg"},{"key":"R15-20250320","doi-asserted-by":"crossref","first-page":"110282","DOI":"10.1016\/j.radonc.2024.110282","article-title":"Could a low-dose definitive radiation therapy be the optimal treatment for choroidal hemangioma?","volume":"196","author":"Wang","year":"2024","journal-title":"Radiother Oncol"},{"key":"R16-20250320","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ijrobp.2010.08.016","article-title":"Gamma knife radiosurgery for choroidal hemangioma","volume":"81","author":"Kim","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250320","first-page":"406","article-title":"Diffuse and circumscribed choroidal hemangiomas in a patient with Sturge-Weber syndrome","volume":"117","author":"Scott","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"R18-20250320","first-page":"E2368","article-title":"Intensity-modulated radiotherapy for head and neck surgeons","volume":"38","author":"Gutiontov","year":"2016","journal-title":"Head Neck"},{"key":"R19-20250320","doi-asserted-by":"crossref","first-page":"100223","DOI":"10.1016\/j.ctarc.2020.100223","article-title":"Aprospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients","volume":"25","author":"Kucha","year":"2020","journal-title":"Cancer Treat Res Commun"},{"key":"R21-20250320","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ijrobp.2004.12.009","article-title":"Does altered fractionation influence the risk of radiation-induced optic neuropathy?","volume":"62","author":"Bhandare","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-20250320","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ijrobp.2004.07.664","article-title":"Preventing radiation retinopathy with hyperfractionation","volume":"61","author":"Monroe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:51:49Z","timestamp":1786647109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00139","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}